Matches in Wikidata for { <http://www.wikidata.org/entity/Q79110642> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q79110642 description "clinical trial" @default.
- Q79110642 description "ensayu clínicu" @default.
- Q79110642 description "klinisch onderzoek" @default.
- Q79110642 description "клінічне випробування" @default.
- Q79110642 description "կլինիկական փորձարկում" @default.
- Q79110642 name "Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma" @default.
- Q79110642 name "Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma" @default.
- Q79110642 type Item @default.
- Q79110642 label "Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma" @default.
- Q79110642 label "Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma" @default.
- Q79110642 prefLabel "Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma" @default.
- Q79110642 prefLabel "Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma" @default.
- Q79110642 P1050 Q79110642-87F464F7-586E-4A39-911E-4B3D987C0FF5 @default.
- Q79110642 P1132 Q79110642-59ABCB49-44CA-4BD0-8E02-25964FA1A11E @default.
- Q79110642 P1476 Q79110642-D8166FB6-1DCA-4665-9DFA-8F9E18B8FF73 @default.
- Q79110642 P2899 Q79110642-DCCEE72E-869D-4DC7-A88A-6F54914F64C6 @default.
- Q79110642 P3098 Q79110642-65693A17-07B6-4EC7-92ED-434D61384386 @default.
- Q79110642 P31 Q79110642-B1ECEB28-2912-4D82-A25B-A372A114375B @default.
- Q79110642 P580 Q79110642-537AD75E-2042-4DD2-A4A3-579C8A6104A4 @default.
- Q79110642 P582 Q79110642-CF6C9FA5-9919-4C3D-90EB-A3421E814703 @default.
- Q79110642 P6099 Q79110642-A2E7EA57-CD4F-4226-8FA8-937FFBDE86ED @default.
- Q79110642 P8363 Q79110642-1C160A87-27C8-458F-96C8-75A7744D26D6 @default.
- Q79110642 P859 Q79110642-46B5DD5E-65AE-4D74-A14B-F53B4EDF1B86 @default.
- Q79110642 P1050 Q33525 @default.
- Q79110642 P1132 "+125" @default.
- Q79110642 P1476 "Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular Carcinoma (HCC)" @default.
- Q79110642 P2899 "+20" @default.
- Q79110642 P3098 "NCT04183088" @default.
- Q79110642 P31 Q30612 @default.
- Q79110642 P580 "2020-03-01T00:00:00Z" @default.
- Q79110642 P582 "2024-03-01T00:00:00Z" @default.
- Q79110642 P6099 Q42824440 @default.
- Q79110642 P8363 Q78089383 @default.
- Q79110642 P859 Q1418766 @default.